Clinical Trial Update: Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluated ascending dosages of moxidectin against ivermectin for Strongyloides stercoralis infection, reporting on efficacy, safety, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Strongyloides Stercoralis Infection

Drugs mentioned

• IVERMECTIN (Ivermectin)
• Moxidectin (moxidectin)

Snippet

Sponsor: Jennifer Keiser | Conditions: Strongyloides Stercoralis Infection | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-12-09